
03/21/2023
African Americans are at disproportionate risk for non-diabetic kidney disease and FSGS in particular. Most of this disparity is due to two variants in the APOL1 gene. These variants confer resistance to trypanosomiasis, a serious disease in some African regions, and as such they have raised in frequency in Africa. Here at the Laboratory of Inherited Kidney Disease we are further investigating the biology that leads this APOL1-related form of kidney disease. If you are African American affected by non-diabetic kidney disease or have a relative with disease and you want to help with our research studies, we would like to hear from you. Feel free to contact us at aknob@bidmc.harvard.edu